22-40261868-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001162501.2(TNRC6B):​c.152C>T​(p.Thr51Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000021 in 1,430,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T51A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

TNRC6B
NM_001162501.2 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.46

Publications

0 publications found
Variant links:
Genes affected
TNRC6B (HGNC:29190): (trinucleotide repeat containing adaptor 6B) Enables RNA binding activity. Involved in regulation of gene expression. Predicted to be located in cytosol. Predicted to be active in P-body and nucleoplasm. Implicated in subserous uterine fibroid and uterine fibroid. [provided by Alliance of Genome Resources, Apr 2022]
TNRC6B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • global developmental delay with speech and behavioral abnormalities
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16510043).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNRC6BNM_001162501.2 linkc.152C>T p.Thr51Met missense_variant Exon 4 of 23 ENST00000454349.7 NP_001155973.1 Q9UPQ9-3
TNRC6BNM_015088.3 linkc.152C>T p.Thr51Met missense_variant Exon 4 of 21 NP_055903.2 Q9UPQ9-1
TNRC6BNM_001024843.2 linkc.260C>T p.Thr87Met missense_variant Exon 7 of 24 NP_001020014.1 Q9UPQ9-2A0A024R1N5
LOC124905121XR_007068107.1 linkn.304-1500G>A intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNRC6BENST00000454349.7 linkc.152C>T p.Thr51Met missense_variant Exon 4 of 23 2 NM_001162501.2 ENSP00000401946.2 Q9UPQ9-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000410
AC:
1
AN:
243702
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000919
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000210
AC:
3
AN:
1430076
Hom.:
0
Cov.:
30
AF XY:
0.00000283
AC XY:
2
AN XY:
706296
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33062
American (AMR)
AF:
0.00
AC:
0
AN:
44298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25706
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38930
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84966
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52374
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5658
European-Non Finnish (NFE)
AF:
0.00000276
AC:
3
AN:
1086454
Other (OTH)
AF:
0.00
AC:
0
AN:
58628
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.016044), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 30, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.152C>T (p.T51M) alteration is located in exon 4 (coding exon 4) of the TNRC6B gene. This alteration results from a C to T substitution at nucleotide position 152, causing the threonine (T) at amino acid position 51 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.53
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.016
.;.;T;.
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.96
D;.;D;D
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
.;.;L;L
PhyloP100
3.5
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.50
N;N;N;N
REVEL
Benign
0.068
Sift
Benign
0.038
D;D;D;D
Sift4G
Benign
0.17
T;T;T;T
Polyphen
0.77
P;P;P;P
Vest4
0.41
MutPred
0.15
.;.;Loss of glycosylation at T51 (P = 0.0079);Loss of glycosylation at T51 (P = 0.0079);
MVP
0.13
MPC
0.32
ClinPred
0.34
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.037
gMVP
0.078
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1442442750; hg19: chr22-40657872; API